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Abstract 
 
Actins are major eukaryotic cytoskeletal proteins, which perform many important cell 
functions, including cell division, cell polarity, wound healing, and muscle contraction. 
Despite obvious drawbacks, muscle actin, which is easily purified, is used extensively 
presently for biochemical studies of actin cytoskeleton from other organisms / cell types. 
Here we report a rapid and cost-effective method to purify heterologous actins 
expressed in the yeast Pichia pastoris. Actin is expressed as a fusion with the actin-
binding protein thymosin 4 and purified using an affinity tag introduced in the fusion. 
Following cleavage of thymosin 4 and the affinity tag, highly purified functional full-
length actin is liberated. We purify actins from S. cerevisiae, S. pombe, and the - and - 
isoforms of human actin. We also report a modification of the method that facilitates 
expression and purification of arginylated actin, a form of actin thought to regulate actin 
dendritic networks in mammalian cells. The methods we describe can be performed in 
all laboratories equipped for molecular biology, and should greatly facilitate biochemical 
and cell biological studies of the actin cytoskeleton. 
 
 
Introduction 
 
Actin is one of the most abundant eukaryotic proteins, which assembles into one of the 
main cytoskeletal polymers in eukaryotic cells. The actin cytoskeleton is vast, and cells 
express hundreds of proteins that associate with actin to control its polymerization, 
stability, spatial organization, and harness it to a wide spectrum of biological tasks, 
including muscle contraction, intracellular transport, cell motility, cell and tissue 
morphogenesis, cell adhesion, transcriptional regulation, and DNA damage (reviewed in 
Misu et al., 2017; Rottner et al., 2017; Skruber et al., 2018). As such, the study of actin 
has extended itself into almost all branches of biological research, creating a major need 
for biochemically characterizing the actin regulatory effects of numerous proteins from 
diverse model organisms, e.g., yeast, flies, worms, and mammals. To date, the majority 
of studies have used skeletal muscle actin (isolated from rabbits or chickens), because 
large quantities can be isolated at a reasonable cost-effectiveness. However, there are 
some major drawbacks to using muscle actin, including the heterogeneity in its post-
translational modifications, and key differences in the properties of muscle actin from 
non-muscle actin isoforms and actin in different species (Bergeron et al., 2010; Kijima et 
al., 2016; Müller et al., 2013; Takaine and Mabuchi, 2007; Ti and Pollard, 2011; Wen et 
al., 2008; Wen and Rubenstein, 2005). These considerations have led to a need to 
develop new methods to purify actins, so that physiologically relevant biochemical and 
cell biological studies may be undertaken. 
 
In this manuscript we describe a method to purify recombinant actin through expression 
in the yeast Pichia pastoris. We purify S. cerevisiae, S. pombe, and - and - isoforms of 
human actin in a form that is functional in vitro and in vivo. 
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Results  
 
To develop an easy and cost-effective method for purification of recombinant actins, we 
used the methylotrophic yeast Pichia pastoris, which is an excellent organism to express 
heterologous proteins (Gellissen, 2000; Macauley-Patrick et al., 2005). To reduce cross-
contamination with endogenous P. pastoris actin, we introduced a strategy that blocks 
co-polymerization of recombinant actin with the host actin, both during cell growth and 
during purification. This was achieved by fusing the actin monomer binding protein 
thymosin 4 (T4) sequence to the C-terminus of the actin coding sequence, with a 
short intervening in-frame linker [schematic in Figure 1A; (Noguchi et al., 2007)]. Fusion 
of actin to T4 leads to intramolecular interactions preventing polymerization of the 
heterologous actin. A His tag (eight consecutive Histidine repeat, 8His) was further 
added to the C-terminus of the actin-T4 fusion to facilitate affinity purification. 
Importantly, since the actin coding sequence ends with a highly conserved 
phenylalanine residue (cleavage site for chymotrypsin), and since all other 
phenylalanine residues are buried (Jacobson and Rosenbusch, 1976), incubation of the 
fusion protein with chymotrypsin releases native, untagged actin. This T4-fusion 
purification approach has been used for heterologous actin expression in Dictyostelium 
and insect cells (Huang et al., 2016; Kijima et al., 2016; Noguchi et al., 2007; Xue et al., 
2014).  However, we reasoned that heterologous actin expression in P. pastoris would 
provide a much easier alternative, which could be used in virtually any laboratory 
equipped for molecular biology. 
 
As a test case, we first expressed actin from Saccharomyces cerevisiae (UniProtKB 
entries: ACT_YEAST) where the actin cytoskeleton has been extensively characterized 
through genetics, biochemistry, and microscopy (Engqvist-Goldstein and Drubin, 2003; 
Moseley and Goode, 2006). Furthermore, since several biochemical studies in S. 
cerevisiae have used native actin purified from yeast cells, we reasoned that the vast 
existing knowledge of S. cerevisiae actin properties would help evaluate the functionality 
of the heterologously expressed S. cerevisiae actin. We were able to purify S. cerevisiae 
actin to near homogeneity after only a small number of steps, including binding to Ni-
NTA resin, cleavage with chymotrypsin, and a cycle of polymerization and 
depolymerization (Figure 1B). The Ni-NTA bound fraction did not contain a prominent 
band at ~42 kDa, suggesting that native P. pastoris actin (UniProtKB entries: 
ACT_KOMPG) did not co-purify appreciably (Figure 1B). Next, we compared the 
polymerization properties of S. cerevisiae actin purified from S. cerevisiae (“Native”) 
versus S. cerevisiae actin purified from P. pastoris (“Recombinant”). We found that actin 
filament elongation rates were nearly identical, both in the presence and absence of a 
yeast formin (Bnr1) and yeast profilin (Pfy1) (Figure 1C and D). As expected, addition of 
Pfy1 alone, without the formin, marginally reduced the rate of elongation of native and 
recombinant Act1 polymers (Figure 1C and D), which we have also observed for profilins 
from several different species. We also found that there was no difference in average 
filament length over time for native and recombinant Act1 (Figure 1C and D). Based on 
these results, we conclude that recombinant Act1 has polymerization properties 
comparable to native Act1, and thus can be used reliably for biochemical studies.  
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To test the versatility of the heterologous actin expression system, we also attempted to 
express and purify fission yeast Schizosaccharomyces pombe actin (UniProtKB entries: 
ACT_SCHPO, “SpAct1”), since this organism has been used extensively in studies of 
the actin cytoskeleton and cytokinesis (Mishra et al., 2014; Pollard and Wu, 2010). We 
expressed and purified SpAct1 as actin-T4-His fusion using the same steps used to 
purify S. cerevisiae actin (Figure 2A). Similar to S. cerevisiae Act1, the Ni-NTA bound 
fraction did not show major contamination with P. pastoris actin (Figure S1A; lane 
marked as uncleaved). N-terminal integrity was confirmed by immunoblotting using 
human -actin antibodies; S. pombe actin was recognized by antibodies against human 
-actin, consistent with the N-terminal sequence conservation between S. pombe and 
human -actin (Figure 2A). We note that SpAct1 was more prone to proteolysis 
compared to S. cerevisiae Act1 (Figure 2A), possibly reflecting some exposure of 
additional chymotrypsin sites.  
 
We next asked whether we could express and purify the two human non-muscle actin 
isoforms, - and -actin (UniProtKB entries: ACTB_HUMAN and ACTG_HUMAN, 
respectively). It is noteworthy that preparations of human non-muscle actins expressed 
in insect cells typically contain co-purifying host actin (Bergeron et al., 2010) and actin 
purified from human non-muscle cells or animal sources contains a mixture of - and - 
isoforms. Similar to the yeast actins, the Ni-NTA bound fraction showed no major 
contamination with P. pastoris actin (Figure S1A; lane marked as uncleaved). Mass 
spectrometric analysis of - and - actin detected all peptides derived from trypsin or 
chymotrypsin digestion of the expressed actins including N-terminal unique peptides. 
Mass spectrometry results are shown in supplemental table 1 and 2, and homogeneity 
of the purified actin is discussed in the legend to Figure S2 (see also Figure 4C). 
Immunoblotting of the purified actins with monoclonal antibodies against human - and 
- actin supports N-terminal integrity of these proteins (Figure 2A).  
 
To test the biochemical activities of purified SpAct1, and human - and -actins, we 
performed sedimentation assays in the presence or absence of the actin polymerization 
inhibitor Latrunculin A (LatA) (Figure 2B). In low ionic strength buffer (G-buffer), like 
rabbit muscle actin, all recombinant actins remained in the supernatant fraction after 
ultracentrifugation. However, under polymerization conditions, after the addition of MgCl2 
and KCl, the muscle actin and recombinant actins shifted primarily to the pellet fractions 
indicating polymerization (Figure 2B). Furthermore, although solvent DMSO alone did 
not affect pelleting, incubation with Latrunculin-A blocked the polymerization of all actins. 
Further, in vitro polymerization assays, monitored by rhodamine-phalloidin staining, 
demonstrated that the recombinant S. pombe and human - and -actins polymerized 
normally into filaments (Figure 2C). 
 
To examine whether - and -actins can be incorporated into cellular actin cytoskeletal 
networks, we labelled - and -actins with Alexa Fluor 488 and Tetramethylrhodamine 
(TMR), respectively (schematic representation of the strategy is shown in Figure 3A and 
-actin labelled with Alexa Fluor 488 is shown in Figure 3B), and injected into zebrafish 
embryos. We found that both actin isoforms could be efficently incorporated into the 
actin cytoskeleton at cell-cell contacts (Figure 3C). In addition, we injected - and -
actins labelled with Alexa Fluor 488 and TMR, respectively, into human RPE1 cells. The 
injected actins co-localized and assembled into native actin cytoskeleton-like structures 
and time-lapse imaging revealed their incorporation into dynamic filamentous structures 
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(Figure 3D and supplemental movie). From these results, we conclude that the labelled 
- and -actins are active and readily decorate filamentous actin networks in RPE cells 
and zebrafish embryos. 
  
Having established a simple method to purify large quantities of heterologous actins in P. 
pastoris, we next adapted this method to the production of arginylated actin, since 
human -actin exists in both arginylated and non-arginylated forms (Karakozova et al., 
2006). Arginylated actin appears to play key roles in actin filament assembly in the 
leading edge dendritic networks. To express and purify arginylated-actin, we created a 
construct, which directs expression of a quadruple fusion containing S. cerevisiae 
ubiquitin-R--actin-T4-His (Figure 4A). This fusion protein was expressed in P. pastoris 
and the ubiquitin moiety was cleaved by the endogenous ubiquitin-specific protease 
(Bachmair et al., 1986). R--actin-T4-His was then purified as before and following 
cleavage with chymotrypsin, R-human -actin (R-Actb) was isolated to near 
homogeneity (results of mass spectrometric analysis are shown in supplemental table 1 
and 2 and the assessment of the homogeneity of the purified actin is discussed in the 
legend to Figure S2). An antibody against arginylated actin strongly recognized R-Actb, 
but only very weakly recognized unmodified Actb (Figure 4B). Mass spectrometric 
analysis detected the N-terminal arginylated peptide (Figure 4C and supplemental table 
1). These results strongly indicated the N-terminal integrity of the R-Actb. Note that R-
Actb runs slightly faster in SDS-PAGE probably reflecting different structural states of 
unmodified and arginylated -actin in complex with SDS (Figure 4B and Figure S1B). 
The faster migration of R-Actb has also been reported by other investigators (Saha et al., 
2010)  We also found the R-Actb could be polymerized in vitro, suggesting that R-Actb 
purified from P. pastoris is functional (Figure 4D). 
 
 
Discussion 
 
In summary, we have developed a simple and rapid method, which requires only 
standard laboratory equipment, to purify large quantities of any specific actin isoform. 
The plasmids we describe will be deposited in Addgene. Investigators should be able to 
clone any actin gene of interest into these vectors, transform P. pastoris, and quickly 
purify the actin for biochemical characterization, and/or labelling and introduction into 
cells for live imaging. 
 
We successfully purified human non-muscle - and -actins, and actins from S. 
cerevisiae and S. pombe. Approximately 0.5-1 mg of actin is purified from a 1 L culture 
of cells grown in standard flasks (about 10 g of cells from 1 L saturated culture). Using 
the method we describe, actin from virtually any eukaryotic organism can be isolated 
and used to study the biochemical effects of actin binding proteins from the same 
species, improving the physiological relevance of the results. This method will also 
enable studies comparing the different actin isoforms, isolated to homogeneity, in the 
absence of other contaminating isoforms. Furthermore, we used this method to produce 
arginylated actin, which opens exciting avenues to characterizing actins with different 
post-translational modifications (Karakozova et al., 2006; Saha et al., 2010; Zhang et al., 
2010). Finally, this method will enable purification to homogeneity of actins carrying point 
mutations that cause different human diseases (Laing et al., 2009; Nowak et al., 1999; 
Rivière et al., 2012), and use these purified mutants in biochemical drug screens. Thus, 
basic and translational studies will be positively impacted by the simple actin purification 
method we describe.  
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Actins undergo a variety of post-translational modifications and although some post-
translational modifications occur in Pichia pastoris, other modifications do not. In future, 
it will be important to develop synthetic biology tools (such as expression of mammalian 
actin acetyl transferases and methyl transferases as well genetic code expansion for 
incorporation of modified amino acids) to express and purify actins carrying other 
modifications. Such tools will both facilitate elucidation of function of various actin 
modifications as well as promote physiologically relevant biochemical and cell biological 
experiments.  
 
 
Methods 
 
Plasmid used in this study 
Actin coding sequences were cloned into pPICZc (invitrogen), which adds at the C-
terminus an in-frame chymotrypsin cleavage site, linker sequence, thymosin 4, and His 
tag(Noguchi et al., 2007). These included Homo sapiens ACTB cDNA, synthesized H. 
sapiens ACTG1 cDNA (codon optimized for Pichia pastoris), the Schizosaccharomyces 
pombe act1 gene, and the Saccharomyces cerevisiae ACT1 gene (codon optimized for 
P. pastoris).  
  
SDS-PAGE and immunoblotting 
Samples were fractionated on 12% SDS-PAGE gels (Acrylamide:bis-acrylamide 37.5:1, 
#1610158, Bio-Rad), and stained with Coomassie Brilliant Blue (CBB) with InstantBlue 
(Expedeon). For immunoblotting, proteins were transferred to a nitrocellulose 
membranes using a semi-dry blotting system (Trans Blot Turbo, BIO-RAD). Membranes 
were incubated at room temperature for 1 h in blocking buffer (5% skimmed milk in TBS 
containing 0.5% Tween 20 and 0.02% NaN3), then incubated in 0.001 v/v% anti-Actb 
(#MABT825, Merck Millipore) or Actg1 (#MABT824, Merck Millipore) antibodies in 
blocking buffer at 4˚C for 2 h. Membranes were washed 4 times with TBS containing 
0.5% tween 20, then incubated with 0.003 v/v% Anti-mouse IgG conjugated with Horse 
Radish Peroxidase (HRP). For immunoblotting in Supplemental figure 2B, HRP-
conjugated antibodies against human actin C-terminus (#sc-1616, Santa Cruz 
Biotechnology) was used to detect -, - and argniylated -actin. Proteins were detected 
with ECL Western Blotting Detecting Reagent (#RPN2106, GE Healthcare). 
 
P. pastoris culture and transformation 
Composition of MGY and MM growth media and basic techniques for P. pastoris X-33 
are described in the Pichia Expression Kit Instruction Manual (Invitrogen). P. pastoris X-
33 was transformed with pPICZc-ACTB, ACTG1 or S. pombe act1 or S. cerevisiae 
ACT1. Plasmid DNA was linearized with PmeI and transformed using the Lithium 
Chloride method. Transformants were selected on Yeast Extract Peptone Dextrose 
(YPD) plates containing 100 mg/L Zeocin (Gibco, #R25001) grown at 30˚C.  
 
Purification of recombinant actins from P. pastoris 
P. pastoris transformants were revived on YPD solid media. Cells were inoculated into 
200 ml minimal glycerol (MGY) liquid media composed of 1.34% yeast nitrogen base 
without amino acids (SIGMA Y0626), 0.00004% biotin and 1% glycerol and cultured at 
30˚C, shaking at 220 rpm. Culture media was diluted 1.5 L by addition of 1.3 L fresh 
MGY media, and cells were cultured at 30˚C, 220 rpm until OD600 = 1.5. Cells were 
pelleted by centrifugation at 7000 rpm at 25˚C for 10 min (Thermo Fisher Scientific #F9-
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6 x 1000 LEX rotor). Cells were washed once with sterilized water and re-suspended 
into 2 L minimal methanol (MM) media, composed of 1.34% yeast nitrogen base without 
amino acids (Sigma Y0626), 0.00004% biotin and 0.5% methanol. Cells were cultured in 
four separate 2 L flasks (500 mL culture each) at 30˚C, 220 rpm for 1.5-2 days. 0.5 % 
methanol was added every 24 h of culturing. Cells were pelleted as above, yielding 
about 10 g wet weight of cells per 1 L culture. Cells were washed once with water and 
resuspended in 30 mL H2O. The suspension was dripped into liquid nitrogen to form 
frozen beads, which were stored at -80˚C until use.  
 
For each preparation, 30 g of frozen cells was used, which was loaded into 8 grinder 
tubes (#6751, SPEX® SamplePrep) pre-cooled with liquid nitrogen and ground in a 
Freezer mill (#6870, SPEX® SamplePrep) in a liquid nitrogen bath. Duration of the 
grinding was 1 min with 14 cycles / second. The grinding was repeated 30 times at 1 min 
intervals. Liquid nitrogen was re-filled every 10 cycles of grinding. The lysate powder 
was resolved in an equal amount of 2 x Binding buffer composed of 20 mM imidazole 
(pH 7.4), 20 mM HEPES (pH 7.4), 600 mM NaCl, 4 mM MgCl2, 2 mM ATP (pH 7), 2x 
concentration of protease inhibitor cocktail (cOmplete, EDTA free #05056489001, 
Roche), 1 mM phenylmethylsulfonyl fluoride (PMSF) and 7 mM -mercaptoethanol (β-
ME). The lysate was sonicated on ice (10 sec with 60% amplitude, Qsonica Sonicators) 
until all aggregates were resolved. The lysate was centrifuged at 4˚C at 4000 rpm for 15 
min (Eppendorf #A-4-81 rotor) to remove intact cells and debris, then further cleared by 
centrifugation at 4˚C at 15000 rpm for 1 h (Thermo Fisher Scientific #A23-6 x 100 rotor). 
The supernatant was passed through a 0.22 µm filter (Corning #431097) and incubated 
with 1 ml Nickel resin (Thermo Scientific #88222) at 4˚C for 1-1.5 h. The resin was 
pelleted down by centrifugation at 4˚C at 2500 rpm for 5 min (Eppendorf #A-4-81 rotor) 
and washed with 25 mL ice-cold binding buffer composed of 10 mM imidazole (pH 7.4), 
10 mM HEPES (pH 7.4), 300 mM NaCl, 2 mM MgCl2, 1 mM ATP (pH 7), protease 
inhibitor cocktail (complete, EDTA free #05056489001, Roche), 1 mM PMSF and 7 mM 
β-ME. The resin was loaded into an open column (BioRad, #731-1550) and washed first 
with ice-cold 20 mL Binding buffer, then with 45 mL ice-cold G-buffer composed of 5 mM 
HEPES (pH 7.4), 0.2 mM CaCl2, 0.01 w/v% NaN3, 0.2 mM ATP (pH 7) and 0.5 mM 
dithiothreitol (DTT). The resin was resuspended in 6 mL ice-cold G-buffer containing 5 
µg/ml TLCK treated chymotrypsin (Sigma #C3142-10MG) and incubated overnight at 
4˚C. The chymotrypsin was inactivated by addition of PMSF to 1 mM and incubated for 
30 min on ice. The eluate was then collected into a tube. Actin retained on the resin was 
eluted with 12 mL G-buffer and all the elution fractions were combined. The eluate was 
concentrated using a 30 kDa cut-off membrane (Sigma-Aldrich #Z677892-24EA) and the 
final volume adjusted to 900 µl with ice-cold G-buffer. Actin was polymerized by addition 
of 100 µl 10x MEK buffer, composed of 20 mM MgCl2, 50 mM glycol-bis(2-
aminoethylether)-N,N,N′,N′-tetraacetic (EGTA) and 1 M KCl for 1 h at room temperature. 
F-actin was pelleted by ultracentrifugation for 1 h at room temperature at 45000 rpm 
(Beckman TLA-55 rotor) and re-suspended in 1 mL ice cold G-buffer. F-actin was 
depolymerized by dialysis against 1 L G-buffer at 4˚C for 2 days. Dialysis buffer was 
exchanged every 12 h. Any remaining F-actin was pelleted by ultracentrifugation at room 
temperature at 45000 rpm for 30 min (Beckman TLA-55 rotor) and actin in the 
supernatant was concentrated to 100 µM using a 30 kDa cut-off membrane (Sigma-
Aldrich #Z677892-24EA). The concentration of actin was determined by absorbance at 
290 nm (ε290 = 0.63 (/mg/ml/cm)) using a NanoDrop 2000c spectrophotometer (Thermo 
Fisher Scientific). 
  
Jo
ur
na
l o
f C
el
l S
ci
en
ce
 •
 A
cc
ep
te
d 
m
an
us
cr
ip
t
  
 
 
 
Purification of native yeast Act1 and recombinant Pfy1 (Profilin) and Bnr1 
Act1 was isolated from S. cerevisiae as described(Cook et al., 1992), except using G-
buffer consisting of 5 mM HEPES, pH 7.6, 0.2 mM CaCl2, 0.2 mM ATP, 2 mM -
mercaptoethanol. Rabbit muscle actin was purified from acetone powder following a 
protocol from Pardee & Spudich(Pardee and Spudich, 1982). Rabbit muscle actin was 
labeled with Oregon Green (OG), and the concentration and labeling efficiency were 
determined as described(Kuhn and Pollard, 2005). 6His-tagged Bnr1 (FH1-FH2-C) was 
overexpressed in S. cerevisiae and purified by nickel chromatography and gel filtration 
as described(Moseley et al., 2006). Untagged S. cerevisiae profilin (Pfy1) was 
expressed and purified from E. coli by anion-exchange chromatography and gel filtration 
as described(Moseley et al., 2004). 
 
Total internal reflection fluorescence (TIRF) microscopy  
Glass coverslips (24 × 60 mm #1.5; Fisher Scientific, Pittsburg, PA) were sonicated for 1 
h in 2% Micro-90 detergent, followed by 1 h sonication in 100% ethanol, then 30 min 
sonication in 0.1 M KOH and ddH20, respectively. Cleaned coverglass was stored in 
100% ethanol prior to use. Before each experiment, coverslips were rinsed with ddH20, 
dried with N2, and coated by applying 120 µL of 2 mg/mL methoxy-poly(ethylene glycol) 
(mPEG)- silane MW 2,000 (Laysan Bio, Arab, AL) and 4 µg/mL biotin-PEG-silane MW 
3,400 (Laysan Bio, Arab, AL) resuspended in 80% ethanol, pH 2.0. Coated coverslips 
were incubated for 16 h at 70ºC. Flow cells were assembled by rinsing PEG-coated 
coverslips with ddH20, drying with N2, and adhering to µ-Slide VI0.1 (0.1 mm × 17 mm × 
1 mm) flow chambers (Ibidi, Martinsried, Germany) with double-sided tape (2.5 cm × 2 
mm × 120 µm) sealed with five-minute epoxy resin (Devcon, Riviera Beach, FL). Flow 
cells were incubated for 1 min with 1% BSA, then incubated for 1 min with TIRF buffer 
(10 mM imidazole pH 7.4, 50 mM KCl, 1 mM MgCl2, 1 mM EGTA, 0.2 mM ATP, 10 mM 
DTT, 15 mM glucose, and 0.25% methyl cellulose [4000 cP]). TIRF reactions were 
initiated by adding 1 µM actin (20% OG-labeled) to premixed actin-binding proteins. 
Reactions were introduced into the flow chamber, which was then mounted on the 
microscope stage for imaging. Time between addition of actin and the start of TIRF 
recording was 180 s. Time lapse imaging was performed on a Nikon-Ti200 inverted 
microscope (Nikon Instruments) equipped with a 488 nm argon laser (150 mW; Melles 
Griot, Carlsbad, CA), a 60× Apo oil-immersion TIRF objective (NA 1.49; Nikon 
Instruments), and an EMCCD camera with a pixel size of 0.267 µm (Andor), and running 
NIS-Elements (Nikon Instruments). Focus was maintained by the Perfect Focus system 
(Nikon Instruments). Images were collected at 5 s intervals for 15 min. Background 
fluorescence was removed from each image in a stack using the background subtraction 
tool (rolling ball radius, 50 pixels) in ImageJ. Minimal contrast enhancement or changes 
to the black level were applied to entire stack to improve image quality for analysis and 
display. Filament elongation rates were determined from n ≥ 10 filaments in each of 
three independent experiments. Filament length was measured using the freehand line 
tool in ImageJ. Elongation rates were determined by plotting filament length versus time, 
where the rate is the slope. To express rates in actin subunits s-1, we used the 
conversion factor of 374 subunits per micron of F-actin.  
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Cysteine labelling with fluorophore-maleimide 
For experiments in which we introduced Alexa-488-actin or TMR-actin into cells, we 
directly labeled Cys374, the C-terminal residue of actin. Actin released by chymotrypsin 
digestion and eluted form the Nickel resin (see purification details above) was 
concentrated to ~1.3 mg/ml, and then polymerized for 1 h at 4˚C by addition of 2 mM 
MgCl2 and 100 mM KCl. Alexa Fluor 488-C5-maleimide (Thermo Fisher Scientific 
#A10254) or Tetramethylrhodamine (TMR)-5-maleimide (Thermo Fisher Scientific 
#T6027) dissolved in dimethyl sulfoxide as a 3 mM stock was added drop-wise to reach 
a 3.5 molar excess of dye to actin, and incubated for 1 h at room temperature in the dark. 
The reaction was quenched by addition of 10 mM DTT, and the reaction was cleared of 
any precipitated dye by centrifugation at 4˚C at 5000 rpm for 10 min (Eppendorf FA-45-
24-11). F-actin was pelleted by ultracentrifugation at room temperature at 45000 rpm for 
1 h (Beckman TLA-55 rotor). The pellet was re-suspended and dialyzed against G-buffer 
to depolymerize actin, as described above, and free fluorophore-maleimide was 
separated from labelled actin using Sephadex G-25 (PD MidiTrap G-25, GE Healthcare 
#28-9180-07). The concentration of fluorophore-labelled actin was measured by 
absorbance at 290 (actin), 495 (Alexa Fluor 488), and 550 nm (TMR) on a NanoDrop 
2000c spectrophotometer (Thermo Fisher Scientific), and calculated using the following 
formula; Actin concentration (M)= A290 / (0.63 x 42000). The extinction coefficient of 
Alexa Fluor 488 at 495 nm is ε495=72,000 M−1 cm−1, with a correction factor for Alexa 
Fluor 488 absorbance at 290 nm of 0.138. Labelling efficiency was calculated as follows; 
(A495 / 72,000) / actin concentration (M). Purified actin was kept on ice in dark. 
 
Mass spectrometry (MS) methods and analysis 
50 µg of each purified protein were separated on 12% SDS-PAGE gel and stained with 
Coomassie G-250 (SimplyBlue SafeStain, Invitrogen). The actin gel band (~42KDa) was 
cut and in gel digested with trypsin and peptides concentrated and desalted on 
StageTips (1) Reversed phase chromatography with two columns, an Acclaim PepMap 
µ-precolumn cartridge 300 µm i.d. x 5 mm, 5 μm, 100 Å and an Acclaim PepMap RSLC 
75 µm i.d. x 50 cm, 2 µm, 100 Å (Thermo Scientific) was used to separate tryptic 
peptides prior to mass spectrometric analysis. The columns were installed on an 
Ultimate 3000 RSLCnano system (Dionex) at 40C. Mobile phase buffer A was 
composed of 0.1% formic acid and mobile phase B was composed of acetonitrile 
containing 0.1% formic acid. Samples were loaded onto the µ-precolumn equilibrated in 
2% aqueous acetonitrile containing 0.1% trifluoroacetic acid for 5 min at 10 µL min-1, 
after which peptides were eluted onto the analytical column at 250 nL min-1 by 
increasing the mobile phase B concentration from 6% B to 25% over 31 min and to 37% 
for 10 min, followed by a 3 min wash at 80% B and a 10 min re-equilibration at 4% B. 
Eluting peptides were converted to gas-phase ions by means of electrospray ionization 
and analysed on a Thermo Orbitrap Fusion (Thermo Scientific). Survey scans of peptide 
precursors from 375 to 1500 m/z were performed at 120K resolution (at 200 m/z) with a 
2x105 ion count target. The maximum injection time was set to 150 ms. Tandem MS 
was performed by isolation at 1.2 Th using the quadrupole, HCD fragmentation with 
normalized collision energy of 33, and rapid scan MS analysis in the ion trap. The MS2 
ion count target was set to 5x103. The maximum injection time was 200 ms. Precursors 
with charge state 2–6 were selected and sampled for MS2. The dynamic exclusion 
duration was set to 40 s with a 10 ppm tolerance around the selected precursor and its 
isotopes. Monoisotopic precursor selection was turned on. The instrument was run in top 
speed mode. The acquired tandem mass spectrometry (MS/MS) mass spectra were 
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processed with SequestHT implemented on the Proteome Discoverer software version 
2.2.0.388 for peptide and protein identifications against Homo sapiens proteome 
(UP000005640, containing 71,544 proteins) and Komagataella phaffii proteome 
(UP000000314, containing 5,073 proteins). The SequestHT node included the following 
parameters: Precursor Mass Tolerance 10 ppm, Fragment Mass Tolerance 0.6 Da, 
Dynamic Modifications were Oxidation of M (+15.995 Da), Acetyl of K (+42.011 Da), 
Methyl of K (+14.016 Da), Phospho of STY (+79.966 Da) and Acetyl protein N-term 
(+42.011 Da). The Static Modification was Carbamidomethyl of C (+57.021 Da). The 
level of confidence for peptide identifications was estimated with the Percolator node 
with decoy database search. FDR was set at 0.01 based on q-value. 
 
F-actin sedimentation assays and imaging 
Actin (12.5 µM) in G-buffer was mixed with 2 mM MgCl2, 5 mM EGTA and 100 mM KCl 
for 1 h at 24˚C. To make a 0.5 mM Latrunculin A (LatA) solution, 10 mM LatA in dimethyl 
sulfoxide (DMSO) was first diluted to 2 mM with G-buffer, then further diluted to 0.5 mM 
in the reaction mixture (final concentration of DMSO 4%). The reaction mixture was 
ultracentrifuged in an Airfuge (Beckman Coulter) at 25 psi, room temperature for 30 min. 
Pellet and supernatant fractions were analysed on Coomassie-stained gels. For imaging 
actin filaments, actin (8.33 µM) in G-buffer was polymerized by addition of 2 mM MgCl2, 
5 mM EGTA, 100 mM KCl and 2% polyethylene glycol 20,000 (#8.17018.1000, Merck 
Millipore) and incubation at 24˚C for 1 h. 5% (v/v) rhodamine phalloidin (#R415, Thermo 
Fisher Scientific) or phalloidin-CF633 (#00046, Biotium) was added, and F-actin was 
imaged using an Andor Revolution XD spinning disk confocal system on a Nikon Eclipse 
Ti inverted microscope, Nikon Plan Apo Lambda 100×/1.45NA oil immersion objective 
lens, a spinning-disk system (CSU-X1; Yokogawa), and an Andor iXon Ultra EMCCD 
camera. Images were acquired at the pixel size of 80 nm/pixel using the Andor IQ3 
software. Laser lines at a wavelength of 561 or 640 nm was used for excitation. 
 
Actin injection into Zebrafish embryos 
Half mg/ml β- and γ-actin labelled with TMR were diluted tenfold in low ionic strength 
buffer (final composition: 5 mM HEPES (pH 7.4), 0.05 mM CaCl2, 0.0025 w/v% NaN3, 
0.2 mM ATP and 0.5 mM DTT) and cleared polymerized actin by ultracentrifugation with 
Airfuge (BECKMAN COULTER) at 25 psi for 10 minutes at 4˚C. 
Wild type embryos were obtained by natural mating using standard procedures in 
accordance with institutional animal care regulations at the University of Warwick. 
Approx. 0.113 nl of β- and γ-actin with TMR was injected into the blastoderm at the one 
cell stage. Embryos were thence dechorionated, embedded in 1 % low melting agarose 
on No. 0 coverslips (MatTek 35 mm uncoated dishes), and imaged at the animal pole; 
while maintained in egg water at 26°C. Images were acquired using Andor Revolution 
XD confocal systems, assembled on a Nikon Eclipse Ti inverted microscope, a spinning 
disc confocal Yokogawa CSU-X1 unit and an Andor iXon Ultra EMCCD camera. The β-
actin injected embryos were imaged using a Nikon Plan Apo Lambda 20× /0.75NA 
objective lens; with a final pixel size of 0.35 μm/pixel using Andor IQ3 software. The γ-
actin injected embryos were imaged using a Nikon Plan Apo Lambda 10× /0.45NA 
objective lens; with a final pixel size of 0.8 μm/pixel using Andor IQ3 software. A 561 nm 
laser lines was used for excitation. All images were acquired with a Z-step size of 0.5 
mm. The image stacks were projected along the Z-axis (maximum intensity) using Fiji 
(Schindelin et al., 2012). 
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Cell culture 
Immortalized (hTERT) diploid human retinal pigment epithelial (RPE1) cells were grown 
in DMEM/F-12 medium containing 10% fetal bovine serum (FBS), 2mM L-Glutamine, 
100 U/ml penicillin and 100 μg/ml streptomycin. In each experiment, cells were plated 24 
or 48 hours before imaging into a glass bottom FluoriDish (FD35-100, World Precision 
Instrument, Inc.). 
 
Actin injection into human RPE1 cells and imaging 
0.25 or 0.5 mg/ml -actin labelled with Alexa Flour 488 and -actin with TMR were mixed 
in low ionic strength buffer composed of 5 mM HEPES (pH 7.4), 0.05 mM CaCl2, 0.0025 
w/v% NaN3, 0.2 mM ATP and 0.5 mM DTT and cleared polymerized actin by 
ultracentrifugation with Airfuge (BECKMAN COULTER) at 25 psi for 10 minutes at 4˚C.  
Microinjection was performed on an Olympus IX71 microscope, equipped with a 40x / 
0.6 NA long distance objective and the Integra TI micromanipulator (Research 
Instruments Ltd), using the FemtoJet 4i microinjector (Eppendorf). G-actins were 
microinjected at room temperature into the cytoplasm of RPE1 cells using pre-pulled 
Femtotips II needles (Eppendorf). Tipically, in each experiment, cells from about 10 
different fields were injected. To visualise the DNA, RPE1 cells were incubated, 1 hour 
before the injection, with DMEM/F-12 media containing 0.5M of SiR-DNA far-red probe 
(Spirochrome). Dynamic live movies and static live images were acquired after the 
microinjection was completed. 
Live-cell imaging was performed on an Olympus DeltaVision Elite microscope (Applied 
Precision, LLC) equipped with a Photometrics CoolSNAP HQ camera (Roper Scientific) 
and a stage-top incubator (TokaiHit) to maintain cells at 37ºC and 5% CO2. 
Temperature was further stabilized using a microscope enclosure (Weather station; 
Precision Control) held at 37ºC. Image stacks (10 x 0.5 μm optical sections) were 
acquired using the softWoRX 5.5 software every 10 minutes for a 5 hours period using a 
40x / 1.3 NA oil-immersion objective. In each experiment, about 10 individual fields 
(1024 x1024 pixels) were imaged using the point visit function in softWoRX 5.5. Original 
movies were then deconvolved with the softWoRX 5.5 software and processed with Fiji 
(Schindelin et al., 2012).  
Static live images were acquired using a confocal spinning-disk microscope (VOX 
UltraView; PerkinElmer, UK) equipped with a 100X / 1.4 NA oil-immersion objective and 
a Hamamatsu ORCA-R2 camera, controlled by Volocity 6.0 (PerkinElmer) running on a 
Windows 7 64-bit (Microsoft, Redmond, WA) PC (IBM, New Castle, NY). Temperature 
on the spinning disc was stabilized using a microscope enclosure (Solent Scientific) held 
at 37ºC. Image stacks were acquired over 50 z-slices separated by 0.2µm for a single 
timepoint using the 488, 561 and 640 nm wavelength lasers. Spinning disc images were 
exported from Volocity 6.0 in OME.TIFF format (The Open Microscopy Environment, 
UK). They were deconvolved in the 488 and 561 nm wavelengths within Huygens 4.1 
(SVI), using point spread functions calculated from 100 nm TetraSpeck fluorescent 
microspheres (Invitrogen) using the Huygens 4.1 PSF distiller. Images were 
deconvolved in the 640 nm wavelength within Huygens 4.1 using a theoretical PSF. 
Deconvolved images were exported from Huygens 4.1 in r3d format (Applied Precision, 
Slovakia) and processed with Fiji (Schindelin et al., 2012). 
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Figure 1. Purification of assembly-competent recombinant Saccharomyces 
cerevisiae Act1 from Pichia pastoris  
(A) Flow chart of actin purification method (for details see Materials and Methods). (B) 
Coomassie-stained gel (CBB) showing purified recombinant Saccharomyces cerevisiae 
Act1. Numbering (1-6) at the bottom corresponds to numbers in flow chart in (A). (C) 
TIRF microscopic analysis of actin filament growth, comparing Act1 purified from S. 
cerevisiae (“Native”) and recombinant Act1 (“Recombinant”) purified from P. pastoris, in 
the presence or absence of S. cerevisiae profilin (Pfy1) and formin (Bnr1). All reactions 
contained 10% Oregon green labelled skeletal muscle actin as a tracer. Data are 
averaged from 3 independent experiments (n = 10 filaments per experiment; 30 total). 
Error bars, SE. (D) Actin filament elongation rates calculated from reactions in (C). 
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Figure 2. Purification of recombinant human non-muscle actins and fission yeast 
Act1. 
(A) CBB gel image showing purified recombinant human - (“Actb”), human  (“Actg1”) 
and Schizosaccharomyces pombe (SpAct1) actins. Immunoblotting in the bottom panels 
was performed with antibodies against Actb or Actg1 raised against peptides 
corresponding to the N-terminus of human - and -actins. Since the N-terminus of S. 
pombe Act1 has strong similarity human -actin, the anti-Actg1 antibody could recognize 
S. pombe Act1 as well as -actin (see bottom alignment). (B) Actin sedimentation 
assays. Purified actin in low ionic strength buffer (“G-buffer”) was mixed with KCl, EGTA 
and Mg2+ to induce actin polymerization. Actin sedimentation was tested in the presence 
of 0.5 mM Latrunculin A (“LatA”), solvent control (“DMSO”) and in the absence of DMSO 
or Latrunculin A (“-“). After ultracentrifugation, actin in the pellet (“Pellet”) and 
supernatant (“Sup”) fractions were detected by CBB staining following SDS-PAGE. 
Rabbit muscle actin was used as a positive control. (C) Visualization of F-actin. The 
specified actins were incubated with KCl, EGTA and Mg2+ in the presence of 2% PEG 
and F-actin in all cases was stained with rhodamine-phalloidin and imaged using a 
Nikon inverted microscope fitted with a Yokogawa spinning disk head and an Andor iXon 
camera. Scale bar =5 µm.  
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Figure 3. Recombinant actins were incorporated into actin cytoskeleton networks 
in cells. 
(A and B) Schematic representation and gel image of actin Cys374 labelling method 
(details are shown in Materials and Methods). Eluates collected after chymotrypsin 
treatment (see Figure 1A) were mixed with KCl and Mg2+ to induce polymerization of -
actin (Lane 1) and incubated with Alexa Fluor 488 C5 maleimide to label the 374th amino 
acid residue of -actin in F-actin (Lane 2). The reaction mixture was spun in an 
ultracentrifuge to pellet down F-actin (Lane 3, supernatant [“Sup”]; Lane 4, pellet fraction 
[“Pellet”]). The pellet fraction was suspended in low salt buffer, G-buffer, and dialyzed 
against the same G-buffer. The dialyzed sample (Lane 5) was ultracentrifuged to 
remove F-actin (Lane 6). Free Alexa Fluor 488 C5 maleimide was removed by desalting 
column (Lane 7, “G-25”). (C) Microinjection of -actin (i) and -actin (ii) labelled with 
TMR into zebrafish embryos. Images were acquired using a spinning disc confocal 
microscope. Scale bar =100 µm. (D) Injection of fluorescently labelled - and -actins 
into RPE1 cells. - and -actin were labelled with Alexa Fluor 488 and TMR, respectively 
and injected into human RPE1 cells. Left panel shows maximum projection of all z-axis 
stacks. Right panel shows maximum projection of 24 to 26th z-axis stacks. Scale bar =10 
µm.  
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Figure 4. Purification of arginylated -actin 
(A) Schematic representation of expression of arginylated -actin (R-Actb). (B) 
Immunoblotting and CBB staining showing purified R-Actb. Immunoblotting was 
performed with polyclonal antibodies against arginylated -actin. (C) Representative 
mass spectra of the unique N-terminal tryptic peptide of -actin, -actin and 
arginylated-actin (“(R)-actin”) using HCD fragmentation. The N-terminal (R)-actin 
tryptic unique peptide showed the substitution of Met-Asp by Arg. (D) Visualization of 
arginylated actin (R-Actb) filament. R-Actb were incubated with KCl, EGTA and Mg2+ in 
the presence of 2% PEG and stained with Cy5-phalloidin. Scale bar =5 µm. 
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Supplemental movie. Time-lapse images of RPE cells injected with 
fluorescent labelled β- and γ-actins. 
Time lapse images of microinjected β- and γ-actins in RPE cells. β- and γ-
actin were labelled with Alexa Fluor 488 and TMR, respectively and injected 
into human RPE cells. Scale bar =20 µm. Images were acquired every 10 
minutes. 
J. Cell Sci. 131: doi:10.1242/jcs.213827: Supplementary information
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Supplemental table 1. Peptides from trypsin-digested samples detected 
by mass spectrometric analysis. 
Supplemental table 2. Peptides from chymotrypsin-digested samples 
detected by mass spectrometric analysis. 
J. Cell Sci. 131: doi:10.1242/jcs.213827: Supplementary information
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Click here to Download Table S1
Click here to Download Table S2
